Addition of Metastasis-Directed Therapy Increases PFS in Prostate Cancer
THURSDAY, April 13, 2023 -- The addition of metastasis-directed therapy (MDT), consisting of definitive radiation therapy to all sites of disease, to hormone therapy results in improved progression-free survival for men with oligometastatic prostate...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Pharmaceuticals | Prostate Cancer | Radiation Therapy